Roche launches 2-in-1 biotech drug for breast cancer in India
The two medicines prescribed together is a standard treatment regimen approved in over 100 countries for both early and metastatic HER2-positive breast cancer.
biotech
May 2022
February 2022
May 2021
September 2018
July 2017
Covid-19 put spotlight on vaccines, diagnostics: Mazumdar-Shaw
Resurgence of interest and new technologies bring a huge opportunity for the vaccine development field, says Biocon CMD Kiran Mazumdar-Shaw.
The Ellas of Bharat Biotech: The gift of the jab
Bharat Biotech, founded by Krishna Ella and his wife Suchitra, has been at the forefront of making vaccines for a while. Yet it took a global pandemic for the spotlight to shine on the company.
August records lowest M&A, PE deal values
Average deal size decreased to $19 million, from $178 million recorded in the previous month.
Is Biocon undervalued?
The inability of analysts to fully understand biotech companies is keeping the value of Kiran Mazumdar-Shaw’s company down.
